Periodic Reporting for period 1 - BioFlow (The development of a predictive biomarker for immunotherapy outcome based on flow cytometry test)

Immunotherapy based on immune checkpoint inhibitors (ICIs) has revolutionised the cancer therapy field. ICIs harness the patient’s own immune system to fight cancer, producing unprecedented durable remissions in a subset of patients. Over the last decade, multiple ICIs such...